- This event has passed.
Grand Challenge Awards- Challenge 6: Develop innovative approaches to target the cancer super-controller MYC
February 12, 2016
Myc is a gene that is mutated and persistently switched on in the majority of human cancers – it’s a hallmark of the disease in nearly seven out of ten cases.
Mutant and overactive Myc helps tumours survive, and this strongly suggests that blocking its function would be a powerful approach to treating many types of cancer.
Of course, Myc isn’t the only gene mutation that’s linked to cancer, so why is this a Grand Challenge? It’s partly because the gene makes a protein (called MYC) that is a powerful ‘super controller’–a vital hub at the centre of a vast communication network within cells, and the properties of the MYC protein itself make it really difficult to design a drug against it.
That’s why we’re putting out a call to the global research community – this challenge needs more than just money, it needs new thinking, innovation and a wide range of expertise.